Skip to main content

Ali Ataya, MD : Research

Critical Care Medicine Specialist, Pulmonologist (Lung Specialist)

Rated 4.9 out of 5 stars
Photo of Ali Ataya

Research at a glance

Top areas of exploration

  • Dyspnea , 10 publications
  • Lung Diseases , 6 publications
  • Alcohol Drinking , 6 publications
  • Hypertension, Pulmonary , 5 publications

Research activity

154 publications

790 citations

Why is this important?

Active clinical trials

GB002-3102

This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - 75 Years
Sexes
All
Hemotag
Investigator
Ali Ataya
Status
Accepting Candidates
ROR-PH-303 (APD811-303)

Study ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Phase 2 or Phase 3 study of ralinepag.

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

154 publications

2026

Delayed progressive fibrotic lung disease associated with bilateral silicone breast implant rupture: A case report.

Radiology case reports

PubMed • Publisher's site

2026

Molgramostim improves exercise distance and duration in autoimmune pulmonary alveolar proteinosis: exploratory IMPALA-2 trial data.

Annals of the American Thoracic Society

PubMed • Publisher's site

2026

Pulmonary Arterial Hypertension in Octogenarians: The Pulmonary Hypertension Association Registry

Pulmonary Circulation

Publisher's site

2026

Doxycycline for epistaxis in hereditary hemorrhagic telangiectasia: genotype-stratified outcomes.

Blood vessels, thrombosis & hemostasis

PubMed • Publisher's site